No more needles: developing oral peptide treatments for diabetes

"Professor Brayden’s lab, working with an industry partner, has developed a new nanoparticle that could allow diabetes patients to take insulin and other peptides orally, rather than with an injection.

This led to a wide range of outcomes: an award-winning international documentary film seen by thousands, a patent application, a presentation of the research at the first Keystone Symposium on Drug Delivery in Dublin, and an article in the top-tier journal, the New England Journal of Medicine.

Ultimately, if this discovery is translated into a treatment for diabetes, it will yield profound health impacts for patients, as they will no longer need injections and will comply better with oral medication."